Perceptive Advisors LLC

Orchestra BioMed Holdings, Inc. · 10% Owner

Perceptive Advisors LLC is listed in filings as 10% Owner at Orchestra BioMed Holdings, Inc.. This profile follows SEC Form 4 activity through Apr 23, 2026, including purchase activity and sale activity. Recent filings connect the profile to Orchestra BioMed Holdings, Inc. (OBIO), Nautilus Biotechnology, Inc. (NAUT), MeiraGTx Holdings plc (MGTX), and Lyra Therapeutics, Inc. (LYRA). The current snapshot covers public activity from Jun 17, 2024 to Apr 23, 2026. Reported amounts are shown as $150 to $115.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Orchestra BioMed Holdings, Inc.OBIO$1501.5M sharesBuyAug 1, 2025$0.0001$3.68
Orchestra BioMed Holdings, Inc.OBIO$2M700k sharesBuyAug 1, 2025$2.75$3.68
MeiraGTx Holdings plcMGTX$5M1.3M sharesBuyAug 12, 2024$4.00$12.44
Lyra Therapeutics, Inc.LYRA$8.5k1.9k sharesSellNov 10, 2025$4.54$0.52
Lyra Therapeutics, Inc.LYRA$9.5k2k sharesSellNov 7, 2025$4.75$0.52
Lyra Therapeutics, Inc.LYRA$17k3.2k sharesSellNov 6, 2025$5.18$0.52
Lyra Therapeutics, Inc.LYRA$76k16.6k sharesSellNov 10, 2025$4.54$0.52
Lyra Therapeutics, Inc.LYRA$84k17.7k sharesSellNov 7, 2025$4.75$0.52
Lyra Therapeutics, Inc.LYRA$150k28.9k sharesSellNov 6, 2025$5.18$0.52
Lyra Therapeutics, Inc.LYRA$3.6k883 sharesSellNov 12, 2025$4.06$0.52
Lyra Therapeutics, Inc.LYRA$2.3k537 sharesSellNov 11, 2025$4.31$0.52
Lyra Therapeutics, Inc.LYRA$32k7.9k sharesSellNov 12, 2025$4.06$0.52
Lyra Therapeutics, Inc.LYRA$21k4.8k sharesSellNov 11, 2025$4.31$0.52
Aldeyra Therapeutics, Inc.ALDX$5M3.4M sharesSellApr 3, 2025$1.42$1.69
Adagio Medical Holdings, Inc.ADGM$2M1.3M sharesBuyOct 20, 2025$1.71$0.551
Adagio Medical Holdings, Inc.ADGM$2192.2M sharesBuyOct 20, 2025$0.0001$0.551
Acrivon Therapeutics, Inc. Common StockACRV$353k250k sharesSellApr 29, 2025$1.41$1.75
Acrivon Therapeutics, Inc. Common StockACRV$336k215.3k sharesSellApr 28, 2025$1.56$1.75
Acrivon Therapeutics, Inc. Common StockACRV$2M1.1M sharesSellApr 25, 2025$1.95$1.75
Acrivon Therapeutics, Inc. Common StockACRV$401k298.9k sharesSellMay 1, 2025$1.34$1.75
Acrivon Therapeutics, Inc. Common StockACRV$617k437.9k sharesSellApr 30, 2025$1.41$1.75